- Global Pharma News & Resources

​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​

Lonza Group AG / Key word(s): Bond/Financing
​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​
08.02.2023 / 18:30 CET/CEST

Basel, Switzerland, 08 February 2023 – Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a CHF 300 million straight-bond issue in line with its financing plan for 2023. The bond has a maturity of 6.5 years and an annual coupon of 2.100%.

The issuer is Lonza Swiss Finance Ltd, Basel, and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the SIX Swiss Exchange. The proceeds of the bonds will be used for refinancing and general corporate purposes.


Key Data

Issue Size 6.5-Year Bond: CHF 300 million

Expected Payment Date: 22 February 2023

Maturity: 12 September 2029

Issue Price: 100.241 percent

Redemption Price: 100 percent

Coupon: 2.100 percent p.a.

Joint Lead Managers: Credit Suisse AG, UBS AG and Zürcher Kantonalbank

About Lonza

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients. Our unparalleled breadth of offerings across divisions enables our customers to commercialize their discoveries and innovations in the healthcare industry.

Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With approximately 17,500 full-time employees, we comprise high-performing teams and individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 6.2 billion with a CORE EBITDA of CHF 2.0 billion in Full-Year 2022. Find out more at

Follow @Lonza on LinkedIn
Follow @LonzaGroup on Twitter

Lonza Contact Details

Victoria Morgan
Head of External Communications
Lonza Group Ltd
Tel +41 61 316 2283

Lyle Wheeler
Investor Relations
Lonza Group Ltd
Tel +41 79 154 9522

End of Media Release

Language: English
Company: Lonza Group AG
Münchensteinerstrasse 38
4052 Basel
Phone: +4161 316 81 11
ISIN: CH0013841017
Valor: 1384101
Listed: SIX Swiss Exchange
EQS News ID: 1555389

End of News EQS News Service

Editor Details

Last Updated: 08-Feb-2023